Related Experiment Video
Updated: Aug 8, 2026
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2
Jessy Deshane1, Craig C Garner, Harald Sontheimer
1Department of Neurobiology and Civitan International Research Center, University of Alabama, Birmingham 35294, USA.
Abstract:
Primary brain tumors (gliomas) have the unusual ability to diffusely infiltrate the normal brain thereby evading surgical treatment. Chlorotoxin is a scorpion toxin that specifically binds to the surface of glioma cells and impairs their ability to invade. Using a recombinant His-Cltx we isolated and identified the principal Cltx receptor on the surface of glioma cells as matrix metalloproteinase-2 (MMP-2). MMP-2 is specifically up-regulated in gliomas and related cancers, but is not normally expressed in brain. We demonstrate that Cltx specifically and selectively interacts with MMP-2 isoforms, but not with MMP-1, -3, and -9, which are also expressed in malignant glioma cells. Importantly, we show that the anti-invasive effect of Cltx on glioma cells can be explained by its interactions with MMP-2. Cltx exerts a dual effect on MMP-2: it inhibits the enzymatic activity of MMP-2 and causes a reduction in the surface expression of MMP-2. These findings suggest that Cltx is a specific MMP-2 inhibitor with significant therapeutic potential for gliomas and other diseases that invoke the activity of MMP-2.
Insights
Chlorotoxin (Cltx), a scorpion toxin, targets matrix metalloproteinase-2 (MMP-2) on glioma cells. This interaction inhibits invasion, suggesting Cltx as a potential therapy for brain tumors and MMP-2-related diseases.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biochemistry
Background:
- Primary brain tumors, such as gliomas, exhibit diffuse infiltration, hindering surgical removal.
- Glioma cell invasion is a critical factor in treatment resistance and disease progression.
Purpose of the Study:
- To identify the specific receptor for Chlorotoxin (Cltx) on glioma cells.
- To elucidate the mechanism by which Cltx inhibits glioma cell invasion.
- To evaluate the therapeutic potential of Cltx as an MMP-2 inhibitor.
Main Methods:
- Utilized recombinant His-Cltx to identify Cltx binding sites on glioma cells.
- Investigated the interaction of Cltx with various matrix metalloproteinase (MMP) isoforms (MMP-1, -2, -3, -9).
- Assessed the effect of Cltx on MMP-2 enzymatic activity and surface expression.
Main Results:
- Identified matrix metalloproteinase-2 (MMP-2) as the principal Cltx receptor on glioma cells.
- Demonstrated that Cltx selectively binds to MMP-2, not other MMPs expressed in gliomas.
- Showed that Cltx inhibits MMP-2 enzymatic activity and reduces its surface expression, leading to decreased glioma cell invasion.
Conclusions:
- Chlorotoxin (Cltx) is a specific inhibitor of matrix metalloproteinase-2 (MMP-2).
- The anti-invasive effects of Cltx on gliomas are mediated through its interaction with MMP-2.
- Cltx holds significant therapeutic potential for treating gliomas and other conditions involving MMP-2 activity.
